openPR Logo
Press release

How The Market Developments Of Key Players Impact The Genetic Testing Market? Key Players: Roche Diagnostics Middle East, Luminex Corporation, QIAGEN, 23andMe

05-30-2019 03:31 PM CET | Health & Medicine

Press release from: Global Market Insights Inc.

Genetic Testing Market

Genetic Testing Market

Global Genetic Testing Market is set to exceed USD 22 billion by 2024; according to a new research report by Global Market Insights. Innovation in genetic testing leading to enhanced efficiency, high sensitivity and safety will serve to be a high impact rendering factor. Technological advancement in scientific research as well as research instrument is increasing the importance of genetic testing. Availability of sensitive and efficient DNA sequencing technique for prenatal genetic testing allows detection of minute amount of DNA circulating in the mother’s blood during early stages of pregnancy. Adoption of such non-invasive prenatal testing (NIPT) at a very early stage of pregnancy is increasing worldwide thereby augmenting the industry growth over the forecast period.

Increasing applications of genetic testing for early detection and prevention of oncology and genetic diseases will accelerate the market growth throughout the forecast period. Around 6,00,920 cancer deaths occurred in the U.S. in 2017. Growing awareness among patients pertaining to early diagnosis of diseases will lead to timely treatment resulting in reduced mortality. Rising prevalence of diseases such as cancer, cystic fibrosis, Alzheimer’s and other genetic diseases worldwide will result in increasing number of people undergoing genetic testing for early diagnosis thereby fueling the market growth.

Request for a sample of this research report @ https://www.gminsights.com/request-sample/detail/2490

The genetic testing industry has started to cater the demand for prenatal testing and newborn screening. Testing during pregnancy assists to identify any diseases the fetuses may have, although not all the possible inherited disorders, and help in parents taking decisions. It also helps to reduce miscarriage risks in early stages of pregnancy, an advantage that will highly influence the genetic testing industry.

Newborns can be tested a day or two after birth to detect any disorders and start treatments early, before any critical stage is reached. For instance, a girl born in Wisconsin, USA in 2003 was diagnosed with having phenylketonuria (PKU), an inherited and treatable metabolic disorder, a few days after her birth. Detected through newborn screening process, the ailment does not allow the phenylalanine amino acid to be processed and if untreated could lead to mental retardation. The parents in this case worked with a dietician to develop special diet and formula which she was then restricted to.

Company profiled in this report based on Business overview, Financial data, Product landscape, Strategic outlook & SWOT analysis:
• Natera
• Myriad Genetics
• Counsyl
• MolecularMD
• Genomic Health
• QIAGEN
• 23andMe
• Cepheid
• Abbott Molecular Inc.
• Roche Diagnostics Middle East
• Luminex Corporation
• Celera Genomictree Inc.
• HTG Molecular Diagnostics
• IntegraGen
• LabCorp Diagnostic Laboratories
• Pathway Genomics Corporation
• Sequenom
• Genentech
• Bayer Diagnostics
• Biocartis
• bioMérieux

Reportedly, the treatment worked, and the girl grew up without the threatening life-long disability. Many such instances worldwide have displayed the potential of the genetic testing industry in newborn screening, which is also being affected by the growing consciousness regarding hereditary disorders.

The genetic testing market, estimated to show 11.6% CAGR over 2018-2024, has witnessed phenomenal upsurge in terms of technological progress and commercialization. There are techniques to find out people who are not affected themselves but carry a gene that can induce disease in the next generation. Research in genetic testing is conducted for learning more about the human body and the contribution of genes. A more commonly known use of genetic testing is forensics, where DNA sequences are studied to identify criminals.

U.S. dominated the genetic testing market in 2017 and will witness robust growth during the forecast period. This is attributable to the rising prevalence of genetic diseases, highly advanced infrastructure to support genetic testing and technological advancements in the region. The regulatory support for direct to consumer (DTC) genetic testing coupled with increasing insurance coverage and reduction in the cost of genetic tests is projected to fuel the demand for genetic testing in the U.S.

Genetic testing market in Japan accounted for the largest market share in Asia-Pacific region and is expected to show significant growth over the coming years. This is attributable to factors such as growing advancements in the technology, availability of new tests, rapidly rising patient pool and increasing government investment in R&D. Further, India and China are expected to grow at a faster CAGR due to the increasing disposable income, rising affordability and growing investments in healthcare infrastructure. Aforementioned factors will further fuel the regional growth throughout the forecast period.

Make an inquiry for purchasing this report @ https://www.gminsights.com/inquiry-before-buying/2490

Some of the notable industry players operating in global genetic testing market are 23andMe, Abbott Molecular, Bayer Diagnostics, Biocartis, BioHelix, BioMerieux, BGI, Celera Genomics, Cepheid, Counsyl, deCODEme, Genentech, Genomictree, Genomic Health, HTG Molecular Diagnostics, IntegraGen, LabCorp Diagnostics, Luminex, MolecularMD, Myriad, Natera, PacBio, Pathway Genomics, Qiagen, Roche Diagnostics, Sequenom and Siemens.

Chapter 1. Methodology

1.1. Methodology
1.2. Market definition
1.3. Forecast parameters
1.4. Data sources
1.4.1. Secondary
1.4.1.1. Paid sources
1.4.1.2. Unpaid sources
1.4.2. Primary

Chapter 2. Executive Summary

2.1. Genetic testing industry 360º synopsis, 2013 - 2024
2.1.1. Business trends
2.1.2. Test type trends
2.1.3. Application trends
2.1.4. Regional trends

Chapter 3. Genetic Testing Industry Insights

3.1. Industry segmentation
3.2. Industry landscape, 2013 – 2024
3.3. Industry impact forces

3.3.1. Growth drivers
3.3.1.1. Growing application of genetic testing in oncology and genetic diseases in North America
3.3.1.2. Technological advancement and availability of new tests
3.3.1.3. Consumer interest in personalized medicine in Europe
3.3.1.4. Physician adoption of genetic tests into clinical care
3.3.1.5. Growing demand for direct-to-consumer genetic testing
3.3.2. Industry pitfalls & challenges
3.3.2.1. High cost of genetic testing
3.3.2.2. Dearth of experienced professionals in developing and underdeveloped countries

Browse Full Report Details @ https://www.gminsights.com/industry-analysis/genetic-testing-market

Data Tables

TABLE 1. Genetic testing industry 360° synopsis, 2013 – 2024
TABLE 2. Global genetic testing market, 2013 – 2024 (USD Million)
TABLE 3. Global genetic testing market, by test type, 2013 – 2024 (USD Million)
TABLE 4. Global genetic testing market, by application, 2013 – 2024 (USD Million)
TABLE 5. Global genetic testing market, by region, 2013 – 2024 (USD Million)
TABLE 6. Predictive testing market by region, 2013 – 2024 (USD Million)
TABLE 7. Carrier testing market by region, 2013 – 2024 (USD Million)
TABLE 8. Prenatal and newborn testing market by region, 2013 – 2024 (USD Million)
TABLE 9. Diagnostic testing market, by region, 2013 - 2024, ( USDMillion)
TABLE 10. Pharmacogenomic market, by region, 2013 - 2024, (USD Million)

Global Market Insights Inc. is a global market research and management consulting company catering to leading corporations, non-profit organizations, universities and government institutions. Our main goal is to assist and partner organizations to make lasting strategic improvements and realize growth targets. Our industry research reports are designed to provide granular quantitative information, combined with key industry insights, aimed at assisting sustainable organizational development.

Global Market Insights, Inc.
4 North Main Street
Selbyville, Delaware 19975 USA
Phone: 1-302-846-7766
Toll Free: 1-888-689-0688
Email:sales@gminsights.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release How The Market Developments Of Key Players Impact The Genetic Testing Market? Key Players: Roche Diagnostics Middle East, Luminex Corporation, QIAGEN, 23andMe here

News-ID: 1759749 • Views:

More Releases from Global Market Insights Inc.

Latest Research Report On Agricultural Adjuvants Market 2021. Major Players Included – Dow Dupont Inc., BASF SE, Clariant AG & More
Latest Research Report On Agricultural Adjuvants Market 2021. Major Players Incl …
The agricultural adjuvants market is expected to observe noteworthy growth on account of increasing demand for high-quality crops. Adjuvants commonly act as an additive in pesticides that increase its effectiveness and smoothen its mixing application. The demand for plant protection products in countries like Bangladesh, India, and Vietnam has surged considerably in recent years. Ever-increasing population across developing economies has forced farmers to produce large quantities of high-quality yields. Citing
U.S. Minoxidil Market 2021 Growth Opportunities and Competitive Landscape 2027 - Walmart, Costco Wholesale Corporation, LGM Pharma
U.S. Minoxidil Market 2021 Growth Opportunities and Competitive Landscape 2027 - …
The U.S. minoxidil industry has been impacted by the COVID-19 pandemic in the form of increased stress amid job losses and health issues, creating rising incidences of hair fall and associated problems. The industry is expected to gain commendable proceeds on account of an upsurge in research studies concerned with the effectiveness of minoxidil. Citing one such instance, in January 2021, a study published in the Dermatologic Therapy supported the efficacy
Global Sulfosuccinate Market 2021 Future Growth With Technology and Current Trends to 2024 | MFG Chemicals, Huntsman Corporation, and Stepan Company
Global Sulfosuccinate Market 2021 Future Growth With Technology and Current Tren …
Owing to these factors, estimates have revealed that the global sulfosuccinate market size will exceed USD 475.7 million in annual estimation by 2024. Increasing adoption of high-performance materials that meet application-specific requirements across various industries, including pharmaceuticals will stimulate the need for sulfosuccinate compounds. The surging disposable incomes of consumers mainly across the developing nations have also fueled their spending capacities on household and personal care. Sulfosuccinates are mainly a mild type
By 2026, Graphene Market will register over 35% CAGR | Applied Nanotech, Inc, an …
The global Graphene Market is slated to gain significant momentum over the forthcoming years, as a result of the growing product consumption in the electronics sector, particularly in developing countries. This high consumption can be attributed to its superior qualities such as high electrical conductivity, durability, and toughness. Request a sample of this research report @ https://www.gminsights.com/request-sample/detail/233 Top Key Players in The Market are: Graphenea S.A., Applied Graphene Materials plc, ACS

All 5 Releases


More Releases for Genetic

Genetic Testing Market to Register Growth due to Increasing Prevalence of Geneti …
The prevalence of diseases, including chronic and genetic diseases, is rising at a swift pace. According to the World Health Organization, a genetic disorder named sickle cell anemia is primarily common among people who had ancestors in India, South America, Central America, Sub-Saharan Africa, Mediterranean countries (including Greece, Turkey, and Italy), Cuba, and Saudi Arabia. In addition to this, the high prevalence of chronic diseases, such as cancer, is also
Genetic Testing Market Demand 2018; by Method Molecular Genetic Test/ DNA Test, …
Universal Genetic Testing Market 2018 Research Report implements an exhaustive study on Market Research Future. This Report Cover Key Market Driver, market size, growth rate, opportunities, market Dynamics and Overall Analysis. And also cover the other information such as Genetic Testing market trends, Prominent players, chapter-wise Description followed by various user perceptions and Forecast till 2023. Genetic Testing Market - Global Insights The Global Genetic Testing Market is growing with the rapid
Global Preimplantation Genetic Testing Market: Growing Public-Private Investment …
The report "Preimplantation Genetic Testing Market by Products & Services (Reagents and Consumables, Software and Services and Instruments), Technology (Single-Nucleotide Polymorphism, Next-Generation Sequencing, Fluorescence in Situ Hybridization, Comparative Genomic Hybridization and Polymerase Chain Reaction), Procedure Type (Preimplantation Genetic Screening, and Preimplantation Genetic Diagnosis), Application (Single Gene Disorders, HLA Typing, Structural Chromosomal Abnormalities, X-Linked Disorders, Aneuploidy and Gender Identification), End User (Hospitals, Diagnostic Labs, and Service Providers, Research Laboratories & Academic
Reproductive Genetic Innovations to Discuss Novelties in Preimplantation Genetic …
Reproductive Genetic Innovations (RGI) will be attending and presenting at the 54th Mexican Congress of Reproductive Medicine hosted by the Associacion Mexicana de Medicina de la Reproduccion, A.C. (AMMR). This is the first year RGI has attended and presented at this conference. Booth G-H (July 17th to the 20th) President and Lab Director, Dr. Svetlana Rechitsky, will be giving a lecture on Wednesday afternoon (July 19th) titled, "Novelties in
Breast Cancer Predictive Genetic Testing Market Breast Cancer Predictive Genetic …
For Report Sample Contact: neeraj@kuickresearch.com or +91-11-47067990 Report Table of Contents Cancer Susceptibility Testing 1.1 Prologue to Cancer Susceptibility 1.2 Aspects of Cancer Susceptibility Testing Breast Cancer Susceptibility 2.1 Conceptual of Breast Cancer Susceptibility 2.2 Trail of the Inherited Susceptible Genes Hereditary Breast Cancer Genes 3.1 High Penetrant Genes 3.1.1 Breast Cancer Gene1 (BRCA1) 3.1.2 Breast Cancer Gene 2 (BRCA2)
Rising Prevalence of Genetic Disorders Propels Prenatal and New-born Genetic Tes …
Global Prenatal and New-born Genetic Testing Market: Snapshot Prenatal and new-born genetic tests refer to the systematic diagnostic tests and screenings undertaken to determine the risk of certain genetic disorders in newborn children and fetuses in stages as early as eight to ten weeks of gestation. The use of a variety of screening and diagnostic tools for detecting chromosomal abnormalities and the risk of diseases such as Patau syndrome, Down